ROBERT W. ROSS
CIK 1733077 · Chief Executive Officer · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
21
Lifetime Open-Market Net
-$428.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XLO | Director | — | $8.31 | — | $0 | 4 | 2025-06-12 |
| Surface Oncology, Inc. (SURF) Delisted | Chief Executive Officer | 0 | $1.07 | $0 | -$428.6K | 17 | 2023-09-08 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-11 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-03 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −1,000 | -$11.3K | EDGAR |
| 2021-01-15 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −9,000 | -$108.2K | EDGAR |
| 2020-12-17 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −1,000 | -$10.5K | EDGAR |
| 2020-12-15 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −1,405 | -$14.1K | EDGAR |
| 2020-11-13 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −595 | -$6.0K | EDGAR |
| 2020-10-16 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −4,000 | -$40.2K | EDGAR |
| 2020-02-05 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
| 2019-03-04 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.